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Hematopoiesis is precisely orchestrated by lineage-specific DNA-binding proteins that regulate transcription in concert
with coactivators and corepressors. Mutations in the zebrafish moonshine (mon) gene specifically disrupt both
embryonic and adult hematopoiesis, resulting in severe red blood cell aplasia. We report that mon encodes the
zebrafish ortholog of mammalian transcriptional intermediary factor 1c (TIF1c) (or TRIM33), a member of the TIF1
family of coactivators and corepressors. During development, hematopoietic progenitor cells in mon mutants fail to
express normal levels of hematopoietic transcription factors, including gata1, and undergo apoptosis. Three different
mon mutant alleles each encode premature stop codons, and enforced expression of wild-type tif1c mRNA rescues
embryonic hematopoiesis in homozygous mon mutants. Surprisingly, a high level of zygotic tif1c mRNA expression
delineates ventral mesoderm during hematopoietic stem cell and progenitor formation prior to gata1 expression.
Transplantation studies reveal that tif1c functions in a cell-autonomous manner during the differentiation of erythroid
precursors. Studies in murine erythroid cell lines demonstrate that Tif1c protein is localized within novel nuclear foci,
and expression decreases during erythroid cell maturation. Our results establish a major role for this transcriptional
intermediary factor in the differentiation of hematopoietic cells in vertebrates.
Citation: Ransom DG, Bahary N, Niss K, Traver D, Burns C, et al. (2004) The zebrafish moonshine gene encodes transcriptional intermediary factor 1c, an essential regulator of
hematopoiesis. PLoS Biol 2(8): e237.
Introduction
Hematopoiesis involves the coordinated processes of cell
proliferation and differentiation of a relatively small number
of progenitor cells into billions of circulating red and white
blood cells (Thisse and Zon 2002). Hematopoiesis in
vertebrates, from zebraﬁsh to humans, is an evolutionarily
conserved program that produces two waves of stem or
progenitor cells that differ both in their embryonic origins
and in the lineages of differentiated blood cells produced
(Palis and Yoder 2001; Orkin and Zon 2002; Galloway and
Zon 2003). The ﬁrst, or primitive, wave of hematopoiesis
originates from ventral mesoderm and gives rise to progen-
itor cells that differentiate in embryonic blood islands. The
primitive wave of hematopoiesis produces a burst of
embryonic erythrocytes and macrophages. The second, or
deﬁnitive, wave of hematopoiesis arises from self-renewing
stem cells that develop primarily in the intraembryonic
aorta–gonad–mesonephros region. These deﬁnitive hemato-
poietic stem cells seed the later developing marrow spaces, to
produce all lineages of adult blood cells, including deﬁnitive
erythrocytes, myeloid cells, and lymphocytes.
We have undertaken a genetic approach to characterize
genes that control hematopoiesis using the zebraﬁsh as a
model system (Thisse and Zon 2002). As part of a large-scale
forward genetic screen, we previously identiﬁed bloodless
zebraﬁsh mutants that failed to express the erythroid tran-
scription factor gata1 normally in embryonic hematopoietic
precursors (Ransom et al. 1996). We named one of these
zebraﬁsh genes moonshine (mon), and another group named a
noncomplementing allele vampire (Weinstein et al. 1996).
Here, we have determined that mutations in the mon gene
cause a disruption in both primitive embryonic and deﬁnitive
adult hematopoiesis, resulting in a severe loss of erythroid
cells. Erythroid progenitor cells in mon mutants are initially
present, but fail to express normal levels of hematopoietic
transcription factors and undergo apoptosis.
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ortholog of mammalian transcriptional intermediary factor 1c
(TIF1c), a member of the TIF1 family of transcriptional
coactivators and corepressors (Le Douarin et al. 1995;
Friedman et al. 1996; Kim et al. 1996; Venturini et al. 1999;
Peng et al. 2002). The three members of the vertebrate TIF1
family (a, b, and c) are large nuclear proteins that each
contain an N-terminal RBCC or TRIM domain (Reymond et
al. 2001) composed of a RING ﬁnger, two B-boxes, and a
coiled-coil domain. TIF1 family members also contain a C-
terminal plant homeodomain ﬁnger and bromodomain that
are characteristic of chromatin remodeling factors. TIF1a has
been shown to associate with a variety of ligand-bound
nuclear hormone receptors (Le Douarin et al. 1995) and
function as a coactivator for retinoic acid receptors (Zhong et
al. 1999). TIF1b has been shown to act as a corepressor for the
large family of Kru ¨ppel-associated box (KRAB) domain zinc-
ﬁnger transcription factors (Friedman et al. 1996; Abrink et
al. 2001). In contrast, TIF1c does not associate directly with
either nuclear receptors or KRAB domains that bind to the
other TIF1 family members (Venturini et al. 1999; Abrink et
al. 2001). Biochemical studies also demonstrate that TIF1c
forms both homo-oligomers and hetero-oligomers with TIF1a
but not with TIF1b (Peng et al. 2002). The murine Tif1a and
Tif1c genes have not yet been subjected to gene targeting
experiments, whereas analysis of mouse mutants demon-
strates that Tif1b is required for postimplantation embryo-
genesis and mesoderm induction in particular (Cammas et al.
2000). Taken together, these studies suggest that a major
function of TIF1 family members is to link DNA-binding
proteins with other coactivators or corepressors during
development.
Our studies establish that tif1c functions as an essential
regulator of embryonic and adult hematopoiesis in verte-
brates. Cell transplantation studies demonstrate that tif1c acts
in a cell-autonomous manner during embryonic hematopoi-
esis. The tif1c gene is expressed speciﬁcally in ventral
mesoderm and hematopoietic progenitors, then downregu-
lated as erythroid maturation occurs. Tif1c protein localizes
to a novel class of nuclear bodies in both primary mouse
embryo ﬁbroblasts and erythroleukemia cell lines. Taken
together, our studies demonstrate that Tif1c is required for
normal erythroid cell development and survival.
Results
The Zebrafish mon Gene Is Essential for Both Primitive and
Definitive Erythropoiesis
In order to determine when the mon gene is required in
development, we ﬁrst examined hematopoietic gene expres-
sion and apoptosis in zebraﬁsh homozygous mon mutant
embryos. During embryogenesis, homozygous zebraﬁsh mon
mutants have no red blood cells (RBCs) visible in circulation
(Ransom et al. 1996; Weinstein et al. 1996). The mon mutants
initiate expression of gata1 in hematopoietic cells around the
ﬁve-somite stage, similar to wild-type embryos (data not
shown); however, based on TUNEL staining, the differ-
entiating erythroid cells undergo programmed cell death
from the 12-somite stage to 22 h postfertilization (hpf)
(Figure 1A and 1B, arrows). At 12 somites, gata1 expression is
only slightly reduced. By 18–22 hpf, hematopoietic-speciﬁc
markers such as gata1, scl, gata2, and ikaros are not detected in
the embryonic blood island (Figure 1A and 1B; unpublished
data). The hematopoietic cells are thus correctly speciﬁed
early during the development of mon mutant embryos, but
these precursors undergo cell death. Based on expression of
c-myb and rag1 (Figure 1B, arrows), mon mutants have normal
myeloid and lymphoid development, respectively. In addition
to the deﬁcit of RBCs in mon mutants, there is a prominent
loss of ﬁn-fold and tail mesenchyme (Ransom et al. 1996).
TUNEL staining of mon mutants demonstrates extensive
apoptosis of mesenchymal cells in the trunk and tail bud
regions (Figure 1A and 1B, arrows). The mon gene is thus
required for normal development and survival of both
committed erythroid progenitor cells and posterior mesen-
chymal cells.
We next examined deﬁnitive hematopoiesis in rare surviv-
ing homozygous adult zebraﬁsh mon mutants. Mutations in
mon are generally lethal by 10 to 14 d of development
(Ransom et al. 1996), although rare mon homozygous mutants
(approximately 1 in 500 bloodless embryos) of all tested
alleles survive to adulthood. Adult mon mutants show cardiac
hypertrophy, presumably due to the severe anemia leading to
a high output state (Figure 2). In wild-type zebraﬁsh, the adult
site of hematopoiesis is the kidney (Al Adhami and Kunz
1977), which contains erythroid, lymphoid, and myeloid
populations at various stages of differentiation (Bennett et
al. 2001). In mon homozygous mutants, there is a severe block
in maturation at the proerythroblast stage (Figure 2), whereas
the differentiation of myeloid cells is normal (unpublished
data). This demonstrates that the mon gene product acts
during both primitive and deﬁnitive erythropoiesis.
Positional Cloning Identifies mon as the Zebrafish
Ortholog of Mammalian TIF1c
We identiﬁed the mon gene by positional cloning using a
panel of 2,200 diploid mutants collected from Tu ¨bingen
background (TU)/WIK strain hybrid parents carrying the
mon
tg234 allele. The mon mutant gene was positioned on
Chromosome 8 between microsatellite markers z987 and
z11001 (Figure 3A) (Knapik et al. 1998). For positional cloning
purposes, over 12,000 polymorphic markers were screened
using ampliﬁed fragment length polymorphism (AFLP)
(Ransom and Zon 1999), and 36 markers within the interval
were isolated. One of these, MA3, was found to be 0.3 cM
from the gene (Figure 3A) and was utilized as the starting
point of a chromosomal walk. A critical P1 bacterial artiﬁcial
chromosome clone (PAC), 107N19, was obtained that
spanned the genetic interval. Two simple sequence confor-
mation polymorphism (SSCP) markers found on this PAC
clone ﬂank the critical genetic interval. The marker 80M12-
T7 maps two recombinants out of 4,400 meioses telomeric of
the mutation, and the marker 157J23-T7 maps one recombi-
nant centromic of the mutation (Figure 3A). The end
sequences and SSCP markers of PAC 107N19 are found in
the zebraﬁsh genomic sequence contig ctg23107 (http://
www.ensembl.org/Danio_rerio/) containing a predicted ze-
braﬁsh TIF1 family gene. This PAC was hybridized to a kidney
cDNA library, resulting in the isolation of four clones that
represented the same gene.
The mon gene encodes a member of the TIF1 family of
transcriptional cofactors (Figure 3B and 3C). The coding
sequence of mon is most similar to human TIFc (Le Douarin et
al. 1995; Friedman et al. 1996; Venturini et al. 1999), and the
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zebraﬁsh and human genes (unpublished data). The mon locus
on zebraﬁsh Chromosome 8 is also predicted to be syntenic to
the region of human Chromosome 1p that contains the TIF1c
gene based on the conserved locations of 12 other ortholo-
gous gene pairs, including NRAS, mapped to these regions in
human and zebraﬁsh (Barbazuk et al. 2000). Therefore, based
on sequence similarity and chromosomal location, the
zebraﬁsh mon gene is the likely ortholog of the human TIF1c
gene.
We have identiﬁed ethyl-nitrosourea (ENU)-induced point
mutations in three alleles of mon (Figure 3C and 3D), each of
which generates a premature stop codon. The mon
tb222b and
mon
tg234 alleles have a severe phenotype with no circulating
blood cells. In contrast, the mon
m262 allele has 10–100
circulating blood cells by 48 hpf, in comparison to the
approximately 3,000 RBCs in the circulation of wild-type or
heterozygous embryos at the same time point. The mon
m262
allele was found to encode a premature stop codon at
position E40, which would encode a putative protein of only
Figure 2. Zebrafish mon Mutants Also Have Severe Defects in Definitive
Hematopoiesis
Adult phenotype of wild-type and mon mutants. A rare surviving
montb222 homozygous adult shows signiﬁcant cardiomegaly in compar-
ison to a wild-type age-matched control. Wright–Giemsa stained
marrow of wild-type adult in comparison to a homozygous mutant.
Note the dramatic reduction of terminally differentiated erythroid
cells and the presence of abnormally large megaloblastic proerythro-
blasts in the mon
tb222 mutant marrow.
DOI: 10.1371/journal.pbio.0020237.g002
Figure 1. Zebrafish mon Mutants Have Severe Defects in Primitive
Hematopoiesis
(A) Whole-mount TUNEL assays reveal that ventral-posterior
mesodermal cells undergo apoptosis in homozygous mon
tg234 mutant
embryos. Whole-mount in situ hybridization of gata1 detected at the
12- and 18-somite stage in genotyped embryos. Posterior views,
anterior to the left.
(B) Extensive apoptosis is visible in the trunk and tail (arrowhead) and
also in hematopoietic cells of the embryonic blood island at 22 h of
development (arrow). Whole-mount in situ hybridization at 22 hpf
including scl, gata2, gata1, ikaros, and myb in mon
tg234 mutants.
Expression of myb is greatly reduced in the blood islands because of
a loss of erythroid cells, but embryonic macrophages are still present
(arrows). The expression of rag1 in thymic T-cells appears normal in
mon mutants at 5 d postfertilization (arrow heads). Lateral views of 22
hpf and 5-d-old embryos.
DOI: 10.1371/journal.pbio.0020237.g001
PLoS Biology | www.plosbiology.org August 2004 | Volume 2 | Issue 8 | e237 1190
moonshine/tif1c in Hematopoiesis40 amino acids. Although this mutation would be expected to
lead to a complete loss of mon gene product, another
methionine is found downstream at amino acid position
104. In vitro translation experiments in reticulocyte lysates
demonstrate reinitiation of translation from this methionine
(unpublished data). Therefore, the hypomorphic larval
phenotype of the mon
m262 allele is likely due to partial loss
of mon function or expression. The presence of mutations in
each of the mon alleles indicates that defective Tif1c function
is the cause of the mon phenotype.
In order to determine whether tif1c is expressed in
hematopoietic mesoderm, we next examined zebraﬁsh
embryos by whole-mount in situ hybridization (Figure 4A).
tif1c mRNA is expressed maternally and is found throughout
the embryo during blastula stages. During gastrulation and
epiboly stages, zygotic expression of mon is highest in the
mesendoderm of the germ ring. At tail bud and early somite
stages a high level of tif1c expression delineates a horseshoe-
shaped population of ventral/lateral mesoderm that will give
rise to blood and also expresses stem cell leukemia hemato-
poietic transcription factor (scl) (Liao et al. 1997). This group
of cells continues to express tif1c and scl while it converges
and forms the embryonic blood island (Detrich et al. 1995).
The tif1c gene is also highly expressed in the central nervous
system as well as the mesenchyme of the trunk and tail.
Homozygous mon
tg234 mutants have a greatly reduced amount
of tif1c mRNA in all tissues consistent with nonsense-
mediated message decay. Thus, zebraﬁsh tif1c is speciﬁcally
expressed in ventral mesoderm and putative hemangioblasts
prior to and during the embryonic stages when hemato-
poietic progenitors are undergoing apoptosis in mon mutants.
We also compared the expression of zebraﬁsh mon to mouse
Tif1c (Figure 4A and 4B). Mouse Tif1c is highly expressed in
erythroid blood islands of the yolk sac, and it is subsequently
expressed in the fetal liver at a high level, and in other tissues,
including the central nervous system. Taken together these
results strongly suggest that zebraﬁsh mon and mouse Tif1c
are orthologs that function during hematopoiesis.
Given that mammalian TIF1c has been shown to form
hetero-oligomers with Tif1a (Peng et al. 2002), we searched
for additional TIF1 family members in zebraﬁsh to compare
with tif1c. Using zebraﬁsh expressed sequence tag (EST)
sequences, we designed primers to RT-PCR amplify a TIF1-
related cDNA from embryonic 10-hpf and 24-hpf RNA. This
cDNA encodes a predicted zebraﬁsh ortholog of human
TIF1a based on predicted amino acid sequences (see Figure
3B). In addition, zebraﬁsh tif1a ESTs map to LG4 in a region
predicted to be syntenic to the region of human Chromo-
some 7 that contains the TIF1a gene based on the conserved
locations of eight other orthologous gene pairs, including
SEMA3A, mapped to these regions in human and zebraﬁsh
(Barbazuk et al. 2000). We next compared the embryonic
Figure 3. Positional Cloning Identifies the
mon Gene as Zebrafish tif1c
(A) Physical map of the mon locus on
zebraﬁsh Chromosome 8. Microsatellite
markers z987 and z11001 were used to
initially identify recombinants in a panel
of 2,200 diploid mon
tg234 homozygous
mutants. The AFLP marker MA3 was
used to initiate a chromosomal walk in
PAC libraries. The critical PACS that
were isolated to encompass the mon locus
are indicated by numbers above bar. The
PAC 107N19 deﬁnes the critical interval
for the mon gene. This PAC was used as a
probe to screen cDNA libraries and to
identify zebraﬁsh tif1c cDNAs. Numbers
below the bar indicate the number of
recombinants identiﬁed by SSCP analy-
sis.
(B) Clustal-W–generated phylogentic
tree of zebraﬁsh (Danio rerio [Dr]) Tif1c
and Tif1a peptide sequences in compar-
ison to TIF1 family members: human
(Hs) TIF1a, TIF1b, and TIF1c; mouse
(Mm) Tif1a, Tif1b, and Tif1c;; and ﬂy
(Dm) bonus.
(C) Diagrams illustrating the structure of
the Tif1c-predicted peptide and the
three identiﬁed point mutants. RING
ﬁnger (RING), B-boxes (B1 and B2), plant
homeodomain ﬁnger (PHD) and bromo-
domain (BROMO). Numbers below the
ﬁrst diagram indicate the percent iden-
tity shared between each of these do-
mains in zebraﬁsh and human TIF1c.
The predicted truncated proteins are
indicated.
(D) DNA sequence chromatograms show-
ing the three ENU-induced point mu-
tants in comparison to wild-type control
sequences
DOI: 10.1371/journal.pbio.0020237.g003
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moonshine/tif1c in Hematopoiesisexpression pattern of tif1a mRNA to tif1c by in situ
hybridization. Like mammalian TIF1a (Le Douarin et al.
1995; Niederreither et al. 1999), the predicted zebraﬁsh tif1c
gene is broadly expressed (see Figure 4A). At ﬁve somites,
zebraﬁsh tif1a does not display the relatively high expression
in the horseshoe-shaped region of hematopoietic mesoderm
seen with tif1c. At later stages, tif1a is evenly expressed
throughout most of the embryo, including the developing
blood islands. Therefore, tif1a is coexpressed in the same cells
with tif1c and may therefore be available to form hetero-
oligomers in vivo.
Forced Expression of tif1c Rescues Hematopoiesis in mon
Mutants
To further conﬁrm that a mutation in the zebraﬁsh tif1c
gene is responsible for the mon mutant phenotype we
performed embryo rescue experiments (Figure 5A; Table 1).
Microinjection of synthetic wild-type mon mRNA at the one-
cell stage rescues the formation of embryonic erythrocytes in
genotyped mutant embryos without causing obvious defects
in embryonic patterning or organogenesis. At 4 d of
development, 70% (n = 10) of mon
tg234 mutants show
signiﬁcant (greater than 200 cells in comparison to a wild-
type estimate of 3,000 cells) rescue of circulating
hemoglobinized RBCs in comparison to control sibling
mutants (n = 75). Based on the correction of the jagged
ﬁn-fold phenotype (Ransom et al. 1996), the mesenchymal
cells are rescued to a similar extent as the anemia
(unpublished data). Overexpression of mon did not result in
expanded blood cell numbers in wild-type embryos and was
not toxic at doses that rescue the phenotype of mon mutants
(unpublished data). Since there were no expanded or ectopic
blood populations in the embryos, these rescue experiments
suggest that mon functions as a permissive factor required for
hematopoiesis.
Marrow Transplantation Rescues Erythropoiesis in mon
Mutants
The high levels of tif1c expression in erythroid cells suggest
that it functions as a cell-autonomous regulator of gene
Figure 4. The mon/tif1c Gene Is Highly
Expressed in Hematopoietic Mesoderm
(A) In situ hybridization of zebraﬁsh
embryos demonstrating the embryonic
expression of tif1c. tif1c is initially ex-
pressed as a maternal mRNA. Increased
expression of tif1c in ventral-lateral
mesoderm begins between the one- to
three-somite stages and increases
through early development. By ﬁve
somites, tif1c is strongly expressed in
lateral stripes of mesoderm that also
express scl. At 22 hpf tif1c is expressed
broadly in the brain, spinal cord, trunk,
and tail mesenchyme, but is at much
higher levels in hematopoietic cells of
the blood island. Zebraﬁsh tif1a is also
broadly expressed but relatively more
uniform in most tissues, in comparison
to tif1c. Tif1a is weakly expressed at early
somite stages in hematopoietic meso-
derm and uniformly expressed at 22 hpf,
including expression in the blood is-
lands. Expression of scl at ﬁve somites
and 22 hpf highlights the embryonic
blood island in comparison to tif1c
expression.
(B) In situ hybridization of mouse em-
bryos detects broad expression of Tif1c
at embryonic day 8.5 including the yolk sac blood islands (arrow). AT embryonic day 12.5, there is high level expression in the fetal liver (arrow)
and broad expression in the embryonic brain, spinal chord, gut, and muscle.
DOI: 10.1371/journal.pbio.0020237.g004
Figure 5. Overexpression of Wild-Type tif1c mRNA or Marrow Trans-
plantation Rescues Embryonic Hematopoiesis in mon Mutants
(A) mon
tg234 mutants are rescued by injection of mRNA-encoding
wild-type Tif1c protein. At 4 d of development, large numbers of
RBCs are visible in the circulation of wild-type zebraﬁsh, shown here
by o-dianisidine staining of hemoglobin. Uninjected mon
ttg234
homozygous mutants are completely bloodless. Injection of 100 pg
of wild-type tif1c mRNA rescues erythropoiesis in mutant embryos. o-
dianisidine-stained larvae are shown in ventral views to highlight
blood in vessels.
(B) Transplantation of wild-type zebraﬁsh marrow cells carrying a
gata1:GFP transgene into 2-d-old embryos reconstitutes erythropoi-
esis, but not viability, in mon
tg234 homozygous mutants. Still frames
from movies of live embryos at day 3 posttransplant highlight less
than 100 GFP
þ RBCs in circulation (top). Transplanted cells were
observed to proliferate resulting in thousands of donor-derived
erythrocytes 7 d later (bottom). Arrows indicate the hearts of control
and transplanted zebraﬁsh. See Videos S1–S4.
DOI: 10.1371/journal.pbio.0020237.g005
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moonshine/tif1c in Hematopoiesisexpression in hematopoietic cells. In order to test this
hypothesis, we transplanted wild-type adult zebraﬁsh kidney
marrow cells carrying a gata1:green ﬂuorescent protein (GFP)
transgene into 48-hpf mon mutant embryos (Figure 5B; Table
2). The gata1:GFP transgene makes use of the gata1 promoter
to drive GFP expression and can thus be used to mark donor-
derived erythroid cells (Long et al. 1997). Untransplanted
mutant embryos have no embryonic blood cells in circu-
lation. Following transplantation, mutant host embryos were
observed daily for 2 wk. Of 191 mutant embryos injected, 129
(68%) showed GFP
þ cells in circulation 2 d later. Many
recipients showed robust increases in donor-derived cells
over the observation period. Of 81 recipients initially scored
as having less than ten GFP
þ cells at day 2 posttransplant, 13
(16%) of these demonstrated a marked increase in erythroid
cells with 100–1,000 GFP
þ cells in circulation 6 d later. By day
10, these transplanted embryos showed approximately 3,000
cells in circulation, similar to the number of blood cells in
normal embryos. Despite robust reconstitution of blood cells,
mutant recipients did not inﬂate their swim bladders and
thus failed to survive longer than nontransplanted sibling
controls, all dying by 3 wk of age. In contrast, 13/35 (37%)
heterozygous mon
tg234 transplants survived to early adulthood.
Similar transplants of wild-type cells can fully rescue vlad tepes
(gata1) mutants (Traver et al. 2003). Therefore, the results of
cell transplantations suggests that tif1c plays a cell-autono-
mous role in erythroid cells, and its role in nonhematopoietic
tissues, such as trunk mesenchyme or the nervous system, is
also required for embryo survival.
Tif1c in Punctate Nuclear Foci Is Developmentally
Regulated
In order to examine the subcellular distribution of Tif1c
protein, we generated an afﬁnity-puriﬁed rabbit polyclonal
antiserum directed against the C-terminal 15 amino acids
conserved in human TIF1c and mouse Tif1c. Immunoﬂuo-
rescence of mouse embryo ﬁbroblast nuclei with the anti-
Tif1c antiserum demonstrates that Tif1c is localized in small
nuclear foci (Figure 6A). The localization of Tif1c protein
appears different from the more diffuse nuclear patterns
typically seen in studies of Tif1a (Remboutsika et al. 2002) or
TIF1b (Cammas et al. 2002). A recent report demonstrates
that TIF1b associates with heterochromatin-containing foci
after retinoic acid treatment or serum starvation (Cammas et
al. 2002). Thus, localization or expression of the TIF1 proteins
may be regulated during distinct developmental processes or
by environmental cues. The nuclear foci that contain Tif1c do
not colocalize with two markers of heterochromatin, HP1a
protein and DAPI staining of DNA (Figure 6A). Furthermore,
Tif1c does not colocalize with promyelocytic leukemia gene
product (PML) nuclear bodies, DNA repair complexes that
contain Mre11, or transcriptional complexes containing TFII-
B (unpublished data). We next examined the expression of
Tif1c protein during the differentiation of G1E cells, a
murine erythroleukemia cell line that can terminally differ-
entiate into erythrocytes when a Gata1:estrogen receptor
fusion protein is stabilized in response to estrogen exposure
(Weiss et al. 1997). Western blot analysis demonstrated that
Tif1c protein expression decreases with terminal erythroid
Table 1. Overexpression of tif1c mRNA Rescues mon Mutants: Hematopoietic Phenotypes
Embryo
Genotypes
Rescue N Number Wild-Type
(Percent)
Number with 100–200 RBCs
(Percent)
Number Bloodless
(Percent)
Wild-type mon mRNA 75 75 (100) 0 0
mon
tg234  /  None 75 0 0 75 (100)
mon
tg234  /  mon mRNA 10 4 (40) 3 (30) 3 (30)
Synthetic tif1c mRNA (100 pg) was injected at the one-cell stage into embryos of the indicated genotypes. For the mon embryos, circulating cells where counted each day
through 4 d, when the embryos were fixed and stained with o-dianisidine to detect hemoglobin in mature RBCs. Normal embryos contain approximately 3,000 circulating
cells at these time points. Results are given as number of embryos with the indicated phenotype. Numbers in parentheses represent percentage of total embryos analyzed.
DOI: 10.1371/journal.pbio.0020237.t001
Table 2. Marrow Transplantation Rescues Hematopoiesis But Not Survival in mon Mutants: Embryos with Transplanted Erythroid Cells
Embryo
Genotypes
Transplant N Number 2 d
Posttransplant (Percent)
Number 8 d
Posttransplant (Percent)
Number Surviving
3 Mo (Percent)
mon
tg234 þ/  gata1:GFP marrow 35 13 (37) 13 (37) 13 (37)
mon
tg234  /  gata1:GFP marrow 191 129 (68) 13 (16) 0
mon
tg234  /  None 50 0 0 0
Between 100 and 1,000 kidney marrow cells from adult gata1:EGFP transgenic donors were injected per zebrafish embryo at 48 hpf. Individual transplanted embryos were
anesthetized and visualized for GFP
þerythroid cells. By 10 d posttransplantation the indicated number of embryos had an estimated 100 to 3,000 GFP
þcells in circulation. At
3 mo the indicated number of fish were alive. The relative percentage of embryos is shown in parentheses.
DOI: 10.1371/journal.pbio.0020237.t002
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moonshine/tif1c in Hematopoiesisdifferentiation (Figure 6B). Consistent with this ﬁnding, after
24 hpf, zebraﬁsh mon mRNA expression falls during the
terminal maturation of the primitive erythroid cells (unpub-
lished data). In two different murine erythroleukemia cell
lines (MEL and G1E), Tif1c is also expressed in nuclear foci,
and even though the overall Tif1c protein level is reduced,
this nuclear foci localization does not change with differ-
entiation (unpublished data). This provides further support
for the hypothesis that Tif1c acts within novel nuclear foci,
during erythroid differentiation.
Discussion
The zebraﬁsh is an excellent model system to elucidate the
molecular machinery controlling gene expression during
hematopoiesis (Thisse and Zon 2002; Galloway and Zon 2003).
As part of a large-scale forward genetic screen, we originally
identiﬁed a complementation group of independent mutant
alleles in the zebraﬁsh gene that we named moonshine (Ransom
et al. 1996). Positional cloning was used to identify the mon
gene, establishing a critical role for a transcriptional
intermediary factor, Tif1c, during hematopoietic develop-
ment.
The mon Gene Encodes the Zebrafish Ortholog of
Mammalian TIF1c
Our results strongly support the conclusion that we have
positionally cloned the zebraﬁsh mon gene correctly, and it is
the ortholog of mammalian Tif1c. Tif1c is present in the
critical genetic interval encompassing a single approximately
50-kb PAC clone deﬁned by linkage analysis (see Figure 3).
Sequence analysis indicates that zebraﬁsh tif1c is most similar
in predicted amino acid sequence and intron/exon structure
compared to the predicted orthologous human and mouse
genes. Zebraﬁsh tif1c is located in a region of zebraﬁsh
Chromosome 8 syntenic to the region of human Chromo-
some 1 containing TIF1c. We identiﬁed point mutations in
tif1c from three different alleles of mon that each result in
premature stop codons and mRNA decay. In addition, tif1c/
Tif1c is highly expressed in hematopoietic cells throughout
embryogenesis in both zebraﬁsh and mouse (see Figure 4).
And as predicted, forced expression of wild-type tif1c mRNA
efﬁciently rescues hematopoiesis in mon mutants and does not
perturb hematopoiesis in wild-type embryos (see Figure 5).
We have also cloned the predicted zebraﬁsh ortholog of tif1a,
which is more uniformly expressed in zebraﬁsh embryos like
mammalian TIF1a (Le Douarin et al. 1995; Niederreither et al.
1999) (see Figures 3A and 4A) and may therefore be available
to form hetero-oligomers with Tif1c protein in developing
hematopoietic cells. Comparing available zebraﬁsh and
mammalian TIF1-predicted amino acid sequences, it appears
that the Tif1c orthologs are the most highly conserved family
members while the Tif1a sequences are relatively more
divergent. We have not found a Tif1b ortholog, thus far, in
the zebraﬁsh or fugu genome or EST sequences. It is possible
that Tif1b, like the KRAB domain transcription factors it
binds to, may be present only in tetrapods (Urrutia 2003).
However, more complete genome sequences will be needed to
conﬁrm this hypothesis. Based on our analysis of zebraﬁsh
mon mutants, it is reasonable to predict that Tif1c, the most
evolutionarily conserved TIF1 family member, plays a
similarly essential role in human and mouse hematopoiesis.
Mutations in tif1c Cause Apoptosis of Erythroid
Progenitors
Our examination of hematopoietic gene expression,
apoptosis, and marrow histology in mon mutants demon-
strates that early erythroid progenitors are formed in
homozygous mutants, but they fail to properly differentiate
and instead undergo programmed cell death (see Figure 1).
The expression of gata1 appears to initiate normally in the
committed erythroid cells of mon mutants. However, the cells
are abnormal prior to the complete loss of gata1 expression.
TUNEL-positive apoptotic cells are abundant by the 12-
somite stage of development, and by 22 hpf all hematopoietic
gene expression is extinguished. The expression of marker
genes, including scl and gata2, characteristic of hematopoietic
stem cells and primitive hematopoietic progenitors, are also
not detected in the embryonic blood islands of mutants at 22
hpf. This indicates that the mutant hematopoietic cells are
not blocked prior to commitment to the erythroid lineage,
but instead develop as abnormal erythroid cells and undergo
apoptosis, similar to gata1-deﬁcient erythroid cells (Fujiwara
Figure 6. Mammalian Tif1c Protein Localizes to Nuclear Bodies Distinct
from Heterochromatin
(A) Deconvolved immunoﬂuorescence images of a mouse embryonic
ﬁbroblast cell nucleus stained with an anti-Tif1c antibody and stained
with a monoclonal antibody directed against HP1a. This is also
compared to DAPI staining. The merged images of the nucleus show
that Tif1c does not colocalize with the HP1a or DAPI staining of
heterochromatin while HP1a and DAPI staining overlap.
(B) G1ER mouse erythroleukemia cells express high levels of Tif1c
protein as detected by Western blot analysis. Expression of Tif1c
decreases during Gata1-dependent erythroid maturation induced by
b-estradiol treatment to induce a Gata1–ER fusion protein.
DOI: 10.1371/journal.pbio.0020237.g006
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moonshine/tif1c in Hematopoiesiset al. 1996; Lyons et al. 2002). Defective erythropoiesis and
severe anemia were also observed in rare surviving homo-
zygous mutant mon adults, demonstrating that tif1c is also
required in deﬁnitive hematopoiesis (see Figure 2).
The zygotic phenotypes of mon mutants may not reveal the
function of maternally inherited Tif1c. Maternally expressed
zebraﬁsh Tif1c may play roles in hematopoiesis or other
aspects of organogenesis that are not detectable due to the
presence of wild-type mRNA in eggs laid by heterozygous
mothers. Analysis of the offspring of homozygous mon mutant
female zebraﬁsh will aid in deﬁning the function of this
maternal mRNA. The present analysis of zygotic mon mutants
provides data that are consistent with the conclusion that
tif1c is essential for erythropoiesis but do not rule out
essential functions in other hematopoietic lineages.
The hematopoietic phenotype of mon mutants resembles
the loss of erythroid cells seen in both mouse Gata1 knockout
embryos and zebraﬁsh vlad tepes (gata1) mutant embryos
(Fujiwara et al. 1996; Lyons et al. 2002). In an effort to
determine if there is a genetic relationship between mon and
gata1, we tested their ability to rescue erythropoiesis. Both
injection of gata1 mRNA into mon homozygous mutant
embryos and injection of tif1c mRNA into gata1 knock-down
embryos failed to rescue hematopoiesis (unpublished data).
We also tested for a direct interaction between Tif1c and
Gata1 proteins by coimmunoprecipitation and yeast two-
hybrid assays and found no association (unpublished data).
Although the mutations in each of these genes arrest cells at a
similar stage of development, our results suggest that gata1
and tif1c act independently. This does not rule out the
possibility that parallel genetic pathways involving gata1 and
tif1c, operating together, regulate gene transcription within
blood cells.
The Role of Tif1c in Primitive and Definitive Erythropoiesis
Taken together, our data suggest that tif1c is required as a
permissive cofactor for the erythroid lineage-speciﬁc control
of hematopoietic gene expression. We reasonably predict
that Tif1c protein functions as a transcriptional intermediary
factor in hematopoietic progenitor cells given that both
TIF1a (Zhong et al. 1999) and TIF1b (Friedman et al. 1996;
Abrink et al. 2001) have been shown to act as intermediary
factors that positively or negatively regulate gene tran-
scription. These studies indicate that TIF1a and TIF1b act
as scaffolds that link different classes of DNA-binding
proteins and chromatin-associated proteins into larger
regulatory complexes. Tif1c is detected within nuclear foci
(see Figure 6), which, based on our analysis, do not appear to
correspond to several types of previously described nuclear
bodies, including PML bodies. Localization of Tif1c to these
nuclear bodies may be regulated by posttranslational
modiﬁcation such as SUMO modiﬁcation that is required
for PML to form PML nuclear domains (Zhong et al. 2000a,
2000b; Best et al. 2002). These foci may serve as assembly
points where Tif1c forms multisubunit complexes with DNA-
binding transcription factors and their other essential
coactivators or corepressors, during the early stages of
erythroid differentiation. It will be important to determine
the identity of Tif1c-interacting proteins in nuclear foci and
establish how they function with Tif1c to regulate blood cell
development.
Materials and Methods
Zebraﬁsh and mouse strains and studies. Zebraﬁsh were main-
tained and staged as described (Westerﬁeld 1998). The alleles mon
tb222b
and mon
tg234 were generated in a large-scale screen for ENU-induced
mutations (Ransom et al. 1996) on the TU, whereas the mon
m262 allele
was derived on the AB strain and was originally called vampire
(Weinstein et al. 1996). Mapping strains were constructed by mating
to WIK or SJD polymorphic strains. Linkage analysis was performed
on haploid or diploid embryos obtained from TU/SJD or TU/WIK
hybrids. In situ hybridization and stainings of embryos were done as
described (Thompson et al. 1998; Liao et al. 2002). In situ hybrid-
ization of mouse embryos was performed as described (Kingsley et al.
2001). Genomic DNA isolation, genotyping, AFLP analysis, and
chromosomal walking were each performed as previously described
(Brownlie et al. 1998; Ransom and Zon 1999). A complete list of
primers for genetic mapping, RT-PCR, and sequencing of mon are
available on request.
mRNA expression constructs, morpholinos, and microinjection.
The full-length mon cDNA was subcloned into EcoRI and XhoI sites in
the pCS2
þ vector. Synthetic mRNA was transcribed in vitro, and
microinjection was performed essentially as described (Liao et al.
2002).
Cell transplantation. Whole kidney marrow cells were isolated
from adult gata1:EGFP transgenic donors, resuspended in 0.9X
phosphate-buffered saline þ 5% fetal bovine serum, and injected
into the sinus venosus of 2-d-old mon
tg234  /  and control embryos.
Between 10
2 and 10
3 kidney marrow cells were injected per embryo.
Individual transplanted embryos were anesthetized and visualized
daily under an inverted ﬂuorescent microscope (DM-IRE2; Leica,
Wetzlar, Germany) for GFP
þ cells over a span of 12 d. On day 13
posttransplant, all surviving larvae (12/129; 9%) were placed in tanks
and monitored for survival.
Antibodies, immunostaining, and immunoblots. Antisera against
the human C-terminal TIF1c sequence RRKRLKSDERPVHIK was
generated in rabbits (Genemed Synthesis, South San Francisco,
California, United States) and afﬁnity puriﬁed. Mouse embryonic
ﬁbroblasts grown on coverslips were immunostained with HP1a
(Chemicon, Temecula, California, United States) and Tif1c antisera
simultaneously. In brief, cells were ﬁxed in 4% paraformaldehyde for
5 min, washed with phosphate-buffered saline, and blocked with 5%
serum (PBST) for 30 min. After incubation with the primary
antibodies (PBST, 60 min) cells were washed three times with PBST
and incubated with secondary antibodies (Jackson Laboratory, Bar
Harbor, Maine, United States) followed by three washes in PBST.
Cells were embedded with Vectashield/DAPI and analyzed using an
Axioplan 2 microscope (Zeiss, Jena, Germany). Digital images were
processed using the Volocity 1.0 software (Improvision, Lexington,
Massachusetts, United States). G1E cell differentiation experiments
were performed essentially as described (Weiss et al. 1997).
Supporting Information
Transplantation of wild-type zebraﬁsh marrow cells carrying a
gata1:GFP transgene into 2-d-old embryos reconstitutes erythropoi-
esis, but not viability, in mon
tg234 homozygous mutants. Movies of live
embryos at day 3 posttransplant highlight less than 100 GFP
þRBCs in
circulation. Transplanted cells were observed to proliferate, resulting
in thousands of donor-derived erythrocytes 7 d later. Movies present
GFP-ﬂuorescent images of live zebraﬁsh larvae.
Video S1. Untransplanted Control mon
tg234 Homozygous Mutants
Had No Fluorescent Cells in Circulation at 3 Days of Development
Found at DOI: 10.1371/journal.pbio.0020237.sv001 (13.7 MB MOV).
Video S2. One Day after Transplantation, Less Than 100 GFP
þ
Erythrocytes Were Visible in the Circulation of Three mon
tg234
Homozygous Mutants
Found at DOI: 10.1371/journal.pbio.0020237.sv002 (11.3 MB MOV).
Video S3. Untransplanted Control mon
tg234 Homozygous Mutants
Had No Fluorescent Cells in Circulation at 9 Days of Development
Found at DOI: 10.1371/journal.pbio.0020237.sv003 (7.9 MB MOV).
Video S4. Seven Days after Transplantation, Thousands of Donor-
Derived Erythrocytes Were Visible in the Circulation of a Repre-
sentative mon
tg234 Homozygous Mutant
Found at DOI: 10.1371/journal.pbio.0020237.sv004 (11.2 MB MOV)
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The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
bers for the genes and gene products discussed in this paper are ﬂy
bonus (AAF19646), human TIF1a (015164), human TIF1b (Q13263),
human TIFc (Q9UPN9), human TIF1c (Q9UPN9), mon (AY59853),
mouse Tif1a (Q64127), mouse Tif1b (AAH58391), and mouse Tif1c
(NP444400).
The cDNA sequences of zebraﬁsh mon/tif1c and tif1a have been
deposited in GenBank under the accession numbers AY598453 and
AY598454, respectively.
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